参苓白术散对稳定期COPD老年患者血清炎性因子与心理状态的影响

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (753 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the curative effect of Shenling Baishu powder combined with respiratory training on serum inflammatory cytokines levels, mental status and cardiac markers of elderly patients with stable chronic obstructive pulmonary disease(COPD). Methods The clinical data of 96 patients with stable COPD treated at Hebei People’s Hospital between January 2016 and August 2017 was retrospectively analyzed. These patients were divided into the control group and treatment group, with 48 cases in each. The control group was treated with western medicines, while the treatment group was additionally given Shenling Baishu powder combined with respiratory training. The mental status, capability of activity, cardiac markers, serum inflammatory cytokines levels, 6-minute walk test and arterial blood gas analysis were observed before and after treatment. Results The total effective rate was 95.83% in the treatment group, compared with 83.33% in the control group (P＜0.05). After one course of treatment, the mental status and ability of activity were improved in both groups (all P＜0.05), especially in the treatment group (P＜0.05). The hs-crp, BNP and results of 6-minute walk test were improved in both groups ( P＜0.05), especially in the treatment group (P＜0.05). PaO₂, SaO₂ and PaCO₂ were also improved in both groups (P＜0.05), especially in the treatment group (P＜0.05). Conclusions Shenling Baishu powder combined with respiratory training can improve the curative effect among elderly patients with stable COPD, reduce levels of serum inflammatory cytokines, and relieve the psychological symptoms of anxiety and depression.

Key words： chronic obstructive pulmonary disease serum inflammatory cytokines elderly mental status stable period

Received: 10 August 2018

ZTFLH:

R563

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Juanjuan
	LIAN Yufei
	YAN Li

Cite this article:

XU Juanjuan,LIAN Yufei,YAN Li. Curative effect of Shenling Baishu Powder on serum inflammatory cytokines and mental status of elderly patients with stable chronic obstructive pulmonary disease[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(4): 295-298.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2019/V30/I4/295

[1]	王华琳,杨敏,侯英宇,等.沙美特罗联合噻托溴铵治疗慢性阻塞性肺疾病的效果[J].武警医学,2017,28(1):30-31,35.
[2]	汪丙柱,吴凌燕,陈琳,等.中医辨证分型对COPD稳定期患者肺功能及hs-CRP、TNF-α的影响[J].中华中医药学刊,2015,33(2):450-452.
[3]	程正良,王胜.慢性阻塞性肺疾病稳定期中医病机“虚、痰、瘀”的理论探讨[J].辽宁中医杂志,2014,41(8):1625-1627.
[4]	李学玲,张春峰.不同剂量舒利迭治疗老年中重度稳定期慢性阻塞性肺疾病疗效观察[J].陕西医学杂志,2016,45(9):1224-1225.
[5]	温学群.羧甲司坦联合沙美特罗替卡松气雾剂治疗对COPD稳定期患者肺功能和炎性因子的影响[J].临床医学工程,2016,23(8):1071-1072.
[6]	陈磊,张国龙,陈敏,等.六君子汤治疗慢性阻塞性肺疾病稳定期肺脾两虚证的疗效观察[J].中医药导报,2015,21(2):79-81.
[7]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.
[8]	中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:54.
[9]	瞿金鸿,林小劲,张辉荣,等.六君子汤+呼吸康复联合西药治疗慢性阻塞性肺疾病稳定期随机平行对照研究[J].实用中医内科杂志,2016,30(5):87-90.
[10]	邹芬芳,高红梅,张健鹏,等.百令胶囊联合桉柠蒎肠溶胶囊治疗稳定期慢性阻塞性肺疾病[J].武警医学,2017,28(11):1121-1123.
[11]	黄莹,黄进,陈少藩,等.金匮肾气丸联合西药治疗老年慢性阻塞性肺疾病稳定期临床观察[J].新中医,2017,49(2):35-38.
[12]	胡晓英,武维屏,牛晓亚.保肺汤加减联合西药治疗30例慢性阻塞性肺疾病稳定期的临床观察[J].现代中医临床,2016,23(4):33-35.
[13]	王昊颖,黄冉.益肺活血颗粒对慢性阻塞肺疾病稳定期患者血清炎性因子的影响及疗效观察[J].中国老年学杂志,2017,37(2):415-417.
[14]	汪丙柱,周国儿,邬易琳,等.补中固卫合剂对慢性阻塞性肺疾病稳定期患者肺功能及细胞因子的影响[J].浙江中医杂志,2015,50(4):241-242.
[15]	王玮,吴海斌,王琦,等.益气化痰祛瘀方治疗COPD稳定期临床疗效观察[J].北京中医药大学学报,2015,38(11):777-780.